对耐火性焦点的三药组合疗法的有效性分析
Chunmei Wu1, Huiting Wu1, Yingying Zhou1
1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.
概括
对于耐药性,lamotrigine/valproic acid/topiramate和lamotrigine/valproic acid/levetiracetam的组合在减少发作方面表现出更高的疗效. 这些疗法在现实临床实践中也表现出良好的耐受性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 耐药性 (DRE) 在治疗选择方面存在重大挑战,特别是多疗法.
- 确定有效的三种药物抗发作药物 (ASM) 组合对于管理DRE至关重要.
- 需要真实世界的数据来评估ASM组合在DRE中的疗效和耐受性.
研究的目的:
- 在现实条件下分析在DRE患者中各种三药ASM组合的有效性.
- 为了在不同的三重治疗方案中比较无率和频率比率 (SFR).
- 评估与特定的三重ASM疗法相关的耐受性和副作用发生率.
主要方法:
- 一个单中心的纵向观察性研究,对323名耐药焦点患者进行了研究.
- 从2019年9月到2022年12月,对76种不同的疗法进行了511次三重ASM试验的评估.
- 通过无率和SFR测量有效性;统计分析包括t测试/曼 - 惠特尼U测试与本雅米尼 - 霍赫伯格调整.
主要成果:
- 总的来说,14.9%的患者通过三重疗法实现了无发作.
- 拉莫/瓦尔酸/托皮拉 (LTG/VPA/TPM) 和LTG/VPA/莱维 (LEV) 的无率最高 (17.9%和12.8%),SFR中位数明显较低 (分别为0.48和0.63).
- 与其他方案 (如LTG/VPA/phenobarbital) 相比,LTG/VPA/TPM和LTG/VPA/LEV表现出良好的耐受性,副作用最小.
结论:
- 拉莫特里金/瓦尔酸/托皮拉和拉莫特里金/瓦尔酸/莱维他雷的组合是治疗耐药性患者的有效和耐受良好的选择.
- 这些发现为临床医生在为具有挑战性的DRE病例选择ASM组合提供了宝贵的指导.
- 进一步的研究可能会探索优化这些和其他三重方案,以改善DRE管理.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
342
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
342
Antiepileptic Drugs: Potassium Channel Activators
181
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
181
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
292
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
292
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antiepileptic Drugs: Sodium Channel Blockers
539
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
539
Antiepileptic Drugs: GABAergic Pathway Potentiators
396
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
396


